4.4 Review

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications

Journal

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY
Volume 5, Issue 2, Pages 201-212

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1586/EGH.11.6

Keywords

apoptosis; caspase inhibitor; cell death; cytokeratin 18; fibrosis; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis

Funding

  1. NIH [DK076852, DK082451]

Ask authors/readers for more resources

Pathological increases in cell death in the liver as well as in peripheral tissues has emerged as an important mechanism involved in the development and progression of nonalcoholic fatty liver disease (NAFLD). An increase in hepatocyte cell death by apoptosis is typically present in patients with NAFLD and in experimental models of steatohepatitis, while an increase in adipocyte cell death in visceral adipose tissue may be an important mechanism triggering insulin resistance and hepatic steatosis. The two fundamental pathways of apoptosis, the extrinsic (death receptor-mediated) and intrinsic (organelle-initiated) pathways, are both involved. This article summarizes the current knowledge related to the distinct molecular and biochemical pathways of cell death involved in NAFLD pathogenesis. In particular, it will highlight the efforts for the development of both novel diagnostic and therapeutic strategies based on this knowledge.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available